Abstract:Background: The degree of gene and sequence preservation across species provides valuable insights into the relative necessity of genes from the perspective of natural selection. Here, we developed novel interspecies metrics across 462 mammalian species, GISMO (Gene identity score of mammalian orthologs) and GISMO-mis (GISMO-missense), to quantify gene loss traversing millions of years of evolution. GISMO is a measure of gene loss across mammals weighed by evolutionary distance relative to humans, whereas GISMO-mis quantifies the ratio of missense to synonymous variants across mammalian species for a given gene. Rationale: Despite large sample sizes, current human constraint metrics are still not well calibrated for short genes. Traversing over 100 million years of evolution across hundreds of mammals can identify the most essential genes and improve gene-disease association. Beyond human genetics, these metrics provide measures of gene constraint to further enable mammalian genetics research. Results: Our analyses showed that both metrics are strongly correlated with measures of human gene constraint for loss-of-function, missense, and copy number dosage derived from upwards of a million human samples, which highlight the power of interspecies constraint. Importantly, neither GISMO nor GISMO-mis are strongly correlated with coding sequence length. Therefore both metrics can identify novel constrained genes that were too small for existing human constraint metrics to capture. We also found that GISMO scores capture rare variant association signals across a range of phenotypes associated with decreased fecundity, such as schizophrenia, autism, and neurodevelopmental disorders. Moreover, common variant heritability of disease traits are highly enriched in the most constrained deciles of both metrics, further underscoring the biological relevance of these metrics in identifying functionally important genes. We further showed that both scores have the lowest duplication and deletion rate in the most constrained deciles for copy number variants in the UK Biobank, suggesting that it may be an important metric for dosage sensitivity. We additionally demonstrate that GISMO can improve prioritization of recessive disorder genes and captures homozygous selection. Conclusions Overall, we demonstrate that the most constrained genes for gene loss and missense variation capture the largest fraction of heritability, GISMO can help prioritize recessive disorder genes, and identify the most conserved genes across the mammalian tree.

A comparative medical genomics approach may facilitate the interpretation of rare missense variation

Leveraging cancer mutation data to predict the pathogenicity of germline missense variants

The landscape of regional missense mutational intolerance quantified from 125,748 exomes

The performance of AlphaMissense to identify genes causing disease

The performance of AlphaMissense to identify genes influencing disease

Genetic constraint at single amino acid resolution in protein domains improves missense variant prioritisation and gene discovery

Comparison of Predicted and Actual Consequences of Missense Mutations.

A New Era in Missense Variant Analysis: Statistical Insights and the Introduction of VAMPP-Score for Pathogenicity Assessment

Discordance between a deep learning model and clinical-grade variant pathogenicity classification in a rare disease cohort

Comprehensive evaluation of AlphaMissense predictions by evidence quantification for variants of uncertain significance

The landscape of gene loss and missense variation across the mammalian tree informs on gene essentiality

Major Causes of Conflicting Interpretations of Variant Pathogenicity in Rare Disease: A Systematic Analysis

AI-derived comparative assessment of the performance of pathogenicity prediction tools on missense variants of breast cancer genes

Critical assessment of missense variant effect predictors on disease-relevant variant data

Using computational approaches to enhance the interpretation of missense variants in the PAX6 gene

Allelic Expression of Deleterious Protein-Coding Variants Across Human Tissues

Performance Evaluation of Pathogenicity-Computation Methods for Missense Variants.

Identification of synonymous pathogenic variants in monogenic disorders by integrating exome with transcriptome sequencing

Functional characterization of all missense variants and comparison to in silico models of pathogenicity

Missense variation affects protein cellular localization